These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1702468)

  • 1. Joint effects of monomer and stabilizer concentrations on physico-chemical characteristics of poly(butyl 2-cyanoacrylate) nanoparticles.
    Alonso MJ; Sanchez A; Torres D; Seijo B; Vila-Jato JL
    J Microencapsul; 1990; 7(4):517-26. PubMed ID: 1702468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization (1): dextran-based surfactants.
    Wu M; Dellacherie E; Durand A; Marie E
    Colloids Surf B Biointerfaces; 2009 Feb; 69(1):141-6. PubMed ID: 19147334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro heterogeneous degradation of poly(n-alkyl alpha-cyanoacrylates).
    Vezin WR; Florence AT
    J Biomed Mater Res; 1980 Mar; 14(2):93-106. PubMed ID: 7188940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres.
    Arias JL; Gallardo V; Ruiz MA; Delgado AV
    Int J Pharm; 2007 Jun; 337(1-2):282-90. PubMed ID: 17223292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of poly(isobutylcyanoacrylate) nanoparticles for mucoadhesive ocular drug delivery. I. Effect of formulation variables on physicochemical characteristics of nanoparticles.
    Das SK; Tucker IG; Hill DJ; Ganguly N
    Pharm Res; 1995 Apr; 12(4):534-40. PubMed ID: 7596988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization. 2. PEG-based surfactants.
    Wu M; Dellacherie E; Durand A; Marie E
    Colloids Surf B Biointerfaces; 2009 Feb; 69(1):147-51. PubMed ID: 19027270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical and morphological characterization of polyisobutyl cyanoacrylate nanocapsules.
    Rollot JM; Couvreur P; Roblot-Treupel L; Puisieux F
    J Pharm Sci; 1986 Apr; 75(4):361-4. PubMed ID: 3723356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monosize poly(ethylcyanoacrylate) microspheres: preparation and degradation properties.
    Tuncel A; Ciçek H; Hayran M; Pişkin E
    J Biomed Mater Res; 1995 Jun; 29(6):721-8. PubMed ID: 7593009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term stability of PBCA nanoparticle suspensions.
    Sommerfeld P; Sabel BA; Schroeder U
    J Microencapsul; 2000; 17(1):69-79. PubMed ID: 10670941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation.
    Huang CY; Lee YD
    Int J Pharm; 2006 Nov; 325(1-2):132-9. PubMed ID: 16857330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of paeonol-loaded poly(butyl-2-cyanoacrylate) nanocapsules by central composite design with response surface methodology together with the antibacterial properties.
    Yao J; Zhang Y; Hu Q; Zeng D; Hua F; Meng W; Wang W; Bao GH
    Eur J Pharm Sci; 2017 Apr; 101():189-199. PubMed ID: 28189814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
    Jin X; Huang A; Ping Q; Cao F; Su Z
    Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tegafur loading and release properties of magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles.
    Arias JL; Ruiz M; Gallardo V; Delgado AV
    J Control Release; 2008 Jan; 125(1):50-8. PubMed ID: 17949844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles.
    Peracchia MT; Vauthier C; Passirani C; Couvreur P; Labarre D
    Life Sci; 1997; 61(7):749-61. PubMed ID: 9252249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer.
    Peracchia MT; Vauthier C; Desmaële D; Gulik A; Dedieu JC; Demoy M; d'Angelo J; Couvreur P
    Pharm Res; 1998 Apr; 15(4):550-6. PubMed ID: 9587950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vivo evaluation of parenteral metoclopramide-loaded poly(alkylcyanoacrylate) nanospheres in rats.
    Radwan MA
    J Microencapsul; 2001; 18(4):467-77. PubMed ID: 11428676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of polymerization technique and experimental variables on the particle properties and release kinetics of methotrexate from poly(butylcyanoacrylate) nanoparticles.
    Reddy LH; Murthy RR
    Acta Pharm; 2004 Jun; 54(2):103-18. PubMed ID: 15274754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(alkylcyanoacrylate) colloidal particles as vehicles for antitumour drug delivery: a comparative study.
    Arias JL; Ruiz MA; López-Viota M; Delgado AV
    Colloids Surf B Biointerfaces; 2008 Mar; 62(1):64-70. PubMed ID: 17961994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of drug-loaded nanoparticles from free drug by gel filtration.
    Beck P; Scherer D; Kreuter J
    J Microencapsul; 1990; 7(4):491-6. PubMed ID: 2266474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation sterilisation of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles.
    Maksimenko O; Pavlov E; Toushov E; Molin A; Stukalov Y; Prudskova T; Feldman V; Kreuter J; Gelperina S
    Int J Pharm; 2008 May; 356(1-2):325-32. PubMed ID: 18295418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.